Levocetirizine Dihcl Pch (Levocetirizine Dihydrochloride)

Levocetirizine selectively antagonizes peripheral histamine H1 receptors. By blocking these receptors, it prevents histamine‑mediated vasodilation, increased vascular permeability, and sensory nerve activation, thereby reducing the inflammatory and itching responses characteristic of allergic conditions.

The appropriate dose is determined by the prescribing clinician based on the patient’s age, severity of symptoms, and renal function. Typically, an oral tablet is taken once daily, but the exact regimen should follow the prescriber’s instructions.

Safety data in pregnancy and lactation are limited. Levocetirizine should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision should be made in consultation with a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levocetirizine is a second‑generation antihistamine offering effective symptom control with a lower incidence of sedation compared with first‑generation agents such as diphenhydramine. It provides a rapid onset of action and is often preferred for patients who need daytime symptom relief without significant drowsiness.

Store the product at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Levocetirizine is taken orally as a tablet. Swallow the tablet whole with a glass of water; it may be taken with or without food, according to the prescriber’s guidance.

Although rare, serious adverse reactions can include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, hepatic enzyme elevations, and, in exceptional cases, cardiac arrhythmias. Patients should seek immediate medical attention if they experience swelling of the face, lips, tongue, or difficulty breathing.

Levocetirizine should not be used by individuals with a known hypersensitivity to levocetirizine or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, and it should be avoided in conjunction with contraindicated drug combinations listed under major interactions.